Gene · 389692
Papers1,763
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,763
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative and integrative single cell analysis reveals new insights into the transcriptional immaturity of stem cell-derived β cells. | BMC Genomics | 2024 | 38267908 | PubTator, text mining | PubMed |
| Expanding Our Knowledge of DICER1 Gene Alterations and Their Role in Thyroid Diseases. | Cancers (Basel) | 2024 | 38254836 | PubTator, text mining | PubMed |
| Sox9 regulates alternative splicing and pancreatic beta cell function. | Nat Commun | 2024 | 38238288 | PubTator, text mining | PubMed |
| "Not even my husband knows that I have this [breast cancer]": survivors' experiences in accessing, navigating and coping with treatment. | Support Care Cancer | 2024 | 38236480 | PubTator, text mining | PubMed |
| Fat mass and obesity-associated (FTO) gene is essential for insulin secretion and β-cell function: In vitro studies using INS-1 cells and human pancreatic islets. | Life Sci | 2024 | 38232799 | PubTator, text mining | PubMed |
| Molecular Pathogenesis of Multiple Myeloma: Clinical Implications. | Hematol Oncol Clin North Am | 2024 | 38199896 | PubTator, text mining | PubMed |
| Metabolic switching, growth kinetics and cell yields in the scalable manufacture of stem cell-derived insulin-producing cells. | Stem Cell Res Ther | 2024 | 38167219 | PubTator, text mining | PubMed |
| EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donors. | Signal Transduct Target Ther | 2024 | 38161208 | PubTator, text mining | PubMed |
| Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas. | Diabetologia | 2024 | 38051360 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis. | Gut | 2024 | 38050068 | PubTator, text mining | PubMed |
| Endoplasmic reticulum stress and pro-inflammatory responses induced by phthalate metabolites monoethylhexyl phthalate and monobutyl phthalate in 1.1B4 pancreatic beta cells. | Toxicology | 2024 | 38048874 | PubTator, text mining | PubMed |
| Transcriptome analysis of Huh7 cells upon Chikungunya virus infection and capsid transfection reveals regulation of distinct cellular and metabolic pathways. | Virology | 2024 | 38043141 | PubTator, text mining | PubMed |
| Oxygenated Scaffolds for Pancreatic Endocrine Differentiation from Induced Pluripotent Stem Cells. | Adv Healthc Mater | 2024 | 37885129 | PubTator, text mining | PubMed |
| Cellular senescence-driven transcriptional reprogramming of the MAFB/NOTCH3 axis activates the PI3K/AKT pathway and promotes osteosarcoma progression. | Genes Dis | 2024 | 37692492 | PubTator, text mining | PubMed |
| Defining unique structural features in the MAFA and MAFB transcription factors that control Insulin gene activity. | bioRxiv | 2024 | 37662349 | PubTator, text mining | PubMed |
| Engineered extracellular vesicles from human skin cells induce pro-β-cell conversions in pancreatic ductal cells. | Adv Nanobiomed Res | 2023 | 38911285 | PubTator, text mining | PubMed |
| Epigenetic modulation of cell fate during pancreas development. | Trends Dev Biol | 2023 | 38873037 | PubTator, text mining | PubMed |
| Topical Insulin in Neurotrophic Keratopathy: A Review of Current Understanding of the Mechanism of Action and Therapeutic Approach. | Pharmaceutics | 2023 | 38276493 | PubTator, text mining | PubMed |
| Characteristics of elderly diabetes patients: focus on clinical manifestation, pathogenic mechanism, and the role of traditional Chinese medicine. | Front Pharmacol | 2023 | 38273819 | PubTator, text mining | PubMed |
| Case report: Insulinomatosis: description of four sporadic cases and review of the literature. | Front Endocrinol (Lausanne) | 2023 | 38264280 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389692/papers?page=5